RxDoctor Payments Data

Ana Cuebas, MD

Psychiatry · Fayetteville, GANPI 1417277997

Payments from drug & device makers

$9,400in general payments, 2019–2025

Across 516 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • AbbVie$1K
  • Indivior Inc.$705
  • Alkermes, Inc.$670
  • plus $3K from 11 others

What the payments were for

  • Food & beverage$9,25098%
  • Education$1502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,400 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$5,872
Medicare patients
14
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine25$105,778
Invega SustennaPaliperidone Palmitate30$93,435
Abilify MaintenaAripiprazole23$66,069
UzedyRisperidone15$49,758
VraylarCariprazine Hcl20$31,979
CaplytaLumateperone Tosylate11$18,127
TrintellixVortioxetine Hydrobromide29$15,025
Clozapine27$5,070
Aripiprazole86$3,439
Divalproex Sodium ErDivalproex Sodium37$1,738
Lurasidone Hcl11$1,661
Ziprasidone Hcl26$1,632
Risperidone OdtRisperidone21$1,487
Olanzapine53$1,393
Buspirone Hcl78$1,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr, Uzedy$1,551$155,53640 claims
Johnson & JohnsonInvega Sustenna$595$93,43530 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$1,691$66,06923 claims
AbbVieVraylar$1,044$31,97920 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,177$18,12711 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$76$15,02529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →